(Q51332817)

3 April 2018

title

Effect of orally administered L. fermentum NCIMB 5221 on markers of metabolic syndrome: an in vivo analysis using ZDF rats. (English)

1 reference

3 April 2018

Catherine Tomaro-duchesneau

1 reference

1

1 reference

3 April 2018

author name string

Shyamali Saha

2

1 reference

3 April 2018

Meenakshi Malhotra

3

1 reference

3 April 2018

Mitchell L Jones

4

1 reference

3 April 2018

Alain Labbé

5

1 reference

3 April 2018

Laetitia Rodes

6

1 reference

3 April 2018

Imen Kahouli

7

1 reference

3 April 2018

Satya Prakash

8

1 reference

3 April 2018

language of work or name

English

0 references

publication date

1 January 2014

1 reference

3 April 2018

Applied Microbiology and Biotechnology

published in

1 reference

3 April 2018

volume

98

1 reference

3 April 2018

page(s)

115-126

1 reference

3 April 2018

issue

1

1 reference

3 April 2018

https://scigraph.springernature.com/pub.10.1007/s00253-013-5252-8

exact match

0 references

cites work

Insulin-releasing properties of a series of cinnamic acid derivatives in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5252-8

Ferulic acid alleviates lipid peroxidation in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5252-8

Microencapsulated bacterial cells can be used to produce the enzyme feruloyl esterase: preparation and in-vitro analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5252-8

Preparation and in vitro analysis of microencapsulated live Lactobacillus fermentum 11976 for augmentation of feruloyl esterase in the gastrointestinal tract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5252-8

Orally delivered microencapsulated live probiotic formulation lowers serum lipids in hypercholesterolemic hamsters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5252-8

Oral probiotic microcapsule formulation ameliorates non-alcoholic fatty liver disease in Bio F1B Golden Syrian hamsters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5252-8

Atherogenic index of plasma [log(triglycerides/HDL-cholesterol)]: theoretical and practical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5252-8

Type 2 diabetes as an inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5252-8

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5252-8

The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5252-8

Glycosylated hemoglobins and long-term blood glucose control in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5252-8

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5252-8

Reactive oxygen species-mediated PKC and integrin signaling promotes tumor progression of human hepatoma HepG2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5252-8

A mutation in succinate dehydrogenase cytochrome b causes oxidative stress and ageing in nematodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5252-8

Cholesterol lowering with bile salt hydrolase-active probiotic bacteria, mechanism of action, clinical evidence, and future direction for heart health applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5252-8

Role of insulin resistance in adipose tissue and liver in the pathogenesis of endogenous hypertriglyceridaemia in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5252-8

Biochemical properties of two cinnamoyl esterases purified from a Lactobacillus johnsonii strain isolated from stool samples of diabetes-resistant rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5252-8

Type 2 diabetes mellitus--current therapies and the emergence of surgical options

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5252-8

DNA repair, genome stability, and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5252-8

A new antidiabetic compound attenuates inflammation and insulin resistance in Zucker diabetic fatty rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5252-8

A spectrophotometric assay for feruloyl esterases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5252-8

Glutamine and its relationship with intracellular redox status, oxidative stress and cell proliferation/death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5252-8

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5252-8

Renoprotective effects of blockade of angiotensin II AT1 receptors in an animal model of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5252-8

Hyperinsulinemia. A link between hypertension obesity and glucose intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5252-8

Impact of recent increase in incidence on future diabetes burden: U.S., 2005-2050.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5252-8

Role of transporter proteins in bile tolerance of Lactobacillus acidophilus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5252-8

The gut microbiota and human health with an emphasis on the use of microencapsulated bacterial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5252-8

Structure-antioxidant activity relationships of flavonoids and phenolic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5252-8

Increased adipogenic conversion of muscle satellite cells in obese Zucker rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5252-8

Evidence for contribution of vascular NAD(P)H oxidase to increased oxidative stress in animal models of diabetes and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5252-8

Protective effects of ferulic acid on hyperlipidemic diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5252-8

Ferulic Acid: therapeutic potential through its antioxidant property.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5252-8

Screening of lactic acid bacteria for bile salt hydrolase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5252-8

A review of the cost of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5252-8

Probiotic Ferulic Acid Esterase Active Lactobacillus fermentum NCIMB 5221 APA Microcapsules for Oral Delivery: Preparation and in Vitro Characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5252-8

Microencapsulation for the Therapeutic Delivery of Drugs, Live Mammalian and Bacterial Cells, and Other Biopharmaceutics: Current Status and Future Directions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5252-8

Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5252-8

Pomegranate flower ameliorates fatty liver in an animal model of type 2 diabetes and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5252-8

Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5252-8

The effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei on gastropathic consequences in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5252-8

10.1007/S00253-013-5252-8

21 January 2018

Identifiers

DOI

1 reference

3 April 2018

PubMed ID

24121931

1 reference

3 April 2018